# Situation: A 45-year-old farmer weighing 60 kg is brought to the emergency department 1 hour after drinking an organophosphate insecticide. He has pinpoint pupils, profuse salivation, wheezing with crackles in both lungs, and a heart rate of 48/min. His clothing has been removed and his skin washed. Atropine is given by the doubling protocol, followed by a continuous infusion. Pralidoxime is also ordered. Why is it given as early as possible?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=630040  
> language: ko  
> subject: Nursing Practice V — Care of Clients with Maladaptive Patterns of Behavior; Care of Clients with Life-Threatening Conditions, Acute Multi-Organ Problems, High Acuity and Emergency Situations

## 문제

Situation: A 45-year-old farmer weighing 60 kg is brought to the emergency department 1 hour after drinking an organophosphate insecticide. He has pinpoint pupils, profuse salivation, wheezing with crackles in both lungs, and a heart rate of 48/min. His clothing has been removed and his skin washed. Atropine is given by the doubling protocol, followed by a continuous infusion.

Pralidoxime is also ordered. Why is it given as early as possible?

## 보기

1. It dries the airway secretions faster than atropine does
2. It stops seizures only while the poison is still in the blood
3. It must bind the poison in the gut before it is absorbed
4. It reactivates the enzyme only before the bond ages **✔ 정답**

**정답: 4**

## 해설

Organophosphates bind acetylcholinesterase, and after a period the bond ages and the enzyme can no longer be reactivated. Pralidoxime reactivates the enzyme only before aging, so it is started early; atropine treats the muscarinic effects.

## 심화 해설

Why pralidoxime must be given early

Organophosphate compounds produce toxicity by phosphorylating the active site of acetylcholinesterase (AChE). Once the enzyme is inhibited, acetylcholine accumulates at cholinergic synapses and the neuromuscular junction, producing the classic cholinergic syndrome seen in this patient: pinpoint pupils, profuse salivation, wheezing with crackles, and bradycardia of 48/min.

Atropine is a competitive muscarinic receptor antagonist. It blocks the effects of excess acetylcholine at muscarinic sites, which is why it dries secretions, dilates pupils, and increases heart rate. However, atropine does nothing to restore the function of the inhibited enzyme. The neuromuscular and central effects, as well as the underlying enzyme blockade, remain untreated.

Pralidoxime (2-PAM) is an oxime that works as a nucleophile. It attacks the phosphorus atom attached to the AChE active site and cleaves the phosphate–enzyme bond, regenerating functional enzyme. This is the only mechanism that directly reverses the biochemical lesion.

The critical limitation is that the organophosphate–enzyme complex undergoes a time-dependent conformational change called aging. During aging, one of the alkyl groups on the phosphorus is lost, and the bond becomes resistant to nucleophilic attack. Once aging has occurred, pralidoxime can no longer reactivate the enzyme, and the inhibition is effectively irreversible. Pralidoxime must therefore be administered before the enzyme–organophosphate bond ages; after aging, the enzyme cannot be reactivated.

The rate of aging varies by agent. With dimethyl organophosphates, aging can occur within minutes to a few hours. With diethyl compounds, the half-life of aging is longer, but clinically meaningful loss of reactivatability still occurs within the first day. This is why the order for pralidoxime specifies administration as early as possible, not as a delayed or rescue measure.

The animal study by Santos et al. supports this timing principle. In rats intoxicated with metamidophos, a single dose of pralidoxime protected against diaphragm muscle necrosis when given at 0, 1, 3, and 6 hours after intoxication, but the protective effect was lost in the group treated at 12 hours [1]. Although the study measured muscle necrosis rather than enzyme reactivation directly, the loss of protection at later time points is consistent with progressive aging of the enzyme–organophosphate complex and declining responsiveness to oxime therapy.

The case report by Bereda describes a patient with diazinon ingestion and reduced serum cholinesterase activity, reinforcing that the clinical syndrome results from AChE inhibition [2]. Marrs et al. note that even in civilian nerve agent exposure, a delay of at least 30 minutes before atropine/oxime administration is expected, and that the organophosphate–enzyme bond may already be aging during that interval [3]. This highlights why early oxime administration is emphasized in every treatment protocol.

The policy analysis by Corby raises questions about the overall clinical efficacy of pralidoxime in certain settings, particularly in large meta-analyses of self-poisoning in resource-limited regions [4]. However, that discussion concerns the magnitude of clinical benefit and the appropriateness of the drug in specific contexts, not the pharmacological mechanism. The rationale for early administration remains unchanged: oxime reactivation is only possible before the phosphorylated enzyme has aged.

| Treatment | Mechanism | Target | Timing limitation |
| --- | --- | --- | --- |
| Atropine | Competitive muscarinic antagonist | Blocks excess acetylcholine at muscarinic receptors | No enzyme reactivation; repeat as needed for secretions and bradycardia |
| Pralidoxime | Nucleophilic oxime; cleaves phosphate–enzyme bond | Reactivates inhibited AChE | Key point! Effective only before aging of the enzyme–OP bond |

Watch out! Do not confuse the roles of atropine and pralidoxime. Atropine treats the muscarinic effects but does not restore enzyme function. Pralidoxime restores enzyme function but does not directly block receptors. They are complementary, not interchangeable.

Watch out! Pralidoxime does not bind the poison in the gut, does not stop seizures selectively, and does not dry secretions faster than atropine. Its sole clinically relevant action is enzyme reactivation, and that action is time-limited by aging.References (research sources)

- [1]Protective effect of early and late administration of pralidoxime against organophosphate muscle necrosis.Research articleSantos RP, Cavaliere MJ, Puga FR, Narciso ES, Pelegrino JR, Calore EE (2002) · DOI: 10.1006/eesa.2001.2138

- [2]Organophosphate Poisoning: Insights From a Case Report of Acute Cholinergic Syndrome.Case reportBereda G. (2025) · DOI: 10.1002/ccr3.71183

- [3]The role of oximes in the treatment of nerve agent poisoning in civilian casualties.Research articleMarrs TC, Rice P, Vale JA (2006) · DOI: 10.2165/00139709-200625040-00009

- [4]Pralidoxime Is no Longer Fit for Purpose as an Antidote to Organophosphate Poisoning in the United Kingdom.Research articleCorby G. (2024) · DOI: 10.1017/dmp.2024.25

## 임상 시나리오

Organophosphate Poisoning: Early PralidoximeWhy timing matters for enzyme reactivation
Organophosphates inhibit acetylcholinesterase by phosphorylating its active site, causing acetylcholine accumulation and cholinergic excess.

Pralidoxime acts as a nucleophile to cleave the phosphate-enzyme bond and restore enzyme function, but only before aging occurs.

Atropine controls muscarinic symptoms such as secretions and bradycardia but does not reactivate the enzyme.

CautionOnce aging occurs, the enzyme-inhibitor bond becomes resistant to reactivation, making early pralidoxime administration critical.

## 핵심 개념

- **Pralidoxime** — An oxime that reactivates organophosphate-inhibited acetylcholinesterase by cleaving the phosphate-enzyme bond before aging occurs.
- **Aging** — Time-dependent conformational change of the organophosphate-enzyme complex that makes the bond resistant to reactivation.
- **Acetylcholinesterase** — Enzyme that breaks down acetylcholine; its inhibition causes cholinergic excess.
- **Atropine** — Competitive muscarinic antagonist used to treat muscarinic effects of organophosphate poisoning.
- **Cholinergic syndrome** — Clinical picture of acetylcholine excess: miosis, salivation, wheezing, bradycardia.

## 같은 주제 문제

- [Situation: A 58-year-old man with severe community-acquired pneumonia is intubated in the …](https://mymerci.kr/pages/nclex_q.php?qn_id=630016)
- [Situation: A 58-year-old man with severe community-acquired pneumonia is intubated in the …](https://mymerci.kr/pages/nclex_q.php?qn_id=630017)
- [Situation: A 58-year-old man with severe community-acquired pneumonia is intubated in the …](https://mymerci.kr/pages/nclex_q.php?qn_id=630018)
- [Situation: A 58-year-old man with severe community-acquired pneumonia is intubated in the …](https://mymerci.kr/pages/nclex_q.php?qn_id=630019)
- [Situation: A 62-year-old man arrives at the emergency department of a provincial hospital …](https://mymerci.kr/pages/nclex_q.php?qn_id=630020)
- [Situation: A 62-year-old man arrives at the emergency department of a provincial hospital …](https://mymerci.kr/pages/nclex_q.php?qn_id=630021)
- [Situation: A 62-year-old man arrives at the emergency department of a provincial hospital …](https://mymerci.kr/pages/nclex_q.php?qn_id=630022)
- [Situation: A 70-year-old woman with rheumatic heart disease is in the coronary care unit. …](https://mymerci.kr/pages/nclex_q.php?qn_id=630023)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._